Keywords: Ruthenium-coordination complex; Ligand exchange rate; Kinase inhibitor; Ruthenium-glutathione-S-transferase inhibitors; DNA damage; Anticancer; 1-BI; 1-benzylimidazole; 2,3-dpp; 2,3-bis(2-pyridyl)pyrazine; 2-ap; 2-acetylpyridine; 3-pyha; 3-pyridinehydroxa